ProterixBio Announces the Appointment of Dr. Fernando Martinez to its Scientific Advisory Board
Billerica, MA – July 13, 2016 – ProterixBio, Inc. today announced that the company has appointed Fernando Martinez, M.D. to its scientific and medical advisory board. Dr. Martinez is a global clinical expert in pulmonary diseases such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). This appointment reflects ProterixBio’s strategic focus on… Read more »
BioScale Announces Company Name Change to ProterixBio and New Focus on Pulmonary Diagnostics and Disease Management
Billerica, MA, May 3, 2016 – BioScale, Inc. today announced that the company is changing its name to ProterixBio, Inc. The name change reflects a new strategic direction centered on high value clinical applications including diagnostics products and disease management services. ProterixBio is developing innovative products to transform the management of chronic diseases, with the… Read more »